#IndustryInsight
Each month we dive into a specific industry to offer tips, trends and insights. If this month’s topic isn’t relevant to you, feel free to scroll on by!
The life sciences industry continues to grow rapidly, rising from USD $88.2B in 2024 to $98.63B in 2025, fueled by major investments in biotechnology, AI, and personalized medicine.
As technology, data, and biology converge, companies are transforming how they discover, develop, and deliver healthcare solutions. Innovations such as AI-driven drug discovery, decentralized trials, and expanded automation are accelerating progress across R&D, manufacturing, and supply chain operations.
To stay competitive, life sciences organizations must adopt new technologies, improve operational efficiency, ensure global compliance, and build strong, cross-functional talent capabilities. Success will increasingly favor companies that can innovate quickly and scale effectively across key emerging trends.
2026 Insights:
• AI/Machine Learning are significantly reducing drug development timelines.
• Automation is speeding up manufacturing and supply chain processes.
• Companies are making substantial investments in global talent, R&D, and delivery centers.
• Cell and gene therapy growth is transforming manufacturing, patient care, and operational models.
Source: Insight Global, 2025